92 related articles for article (PubMed ID: 15128908)
1. A halt to neuroblastoma screening in Japan.
Tsubono Y; Hisamichi S
N Engl J Med; 2004 May; 350(19):2010-1. PubMed ID: 15128908
[No Abstract] [Full Text] [Related]
2. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
3. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma screening in early life.
Collins MH
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
[No Abstract] [Full Text] [Related]
5. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
Nishi M; Takeda T; Hatae Y; Hanai J; Fujita K; Ichimiya H; Tanaka T
J Exp Clin Cancer Res; 2002 Mar; 21(1):73-8. PubMed ID: 12071533
[TBL] [Abstract][Full Text] [Related]
6. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
Soderstrom L; Woods WG; Bernstein M; Robison LL; Tuchman M; Lemieux B
J Natl Cancer Inst; 2005 Aug; 97(15):1118-24. PubMed ID: 16077069
[TBL] [Abstract][Full Text] [Related]
7. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
8. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
9. History and current status of neuroblastoma screening in Japan.
Takeda T
Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
[No Abstract] [Full Text] [Related]
10. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
11. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
12. Screening for neuroblastoma: a resurrected idea?
Maris JM; Woods WG
Lancet; 2008 Apr; 371(9619):1142-3. PubMed ID: 18395561
[No Abstract] [Full Text] [Related]
13. Is the mass screening for neuroblastoma ineffective?
Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
Schilling FH; Oberrauch W; Schanz F; Treuner J
Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
[No Abstract] [Full Text] [Related]
15. Neuroblastoma: the case for screening infants in North America.
Woods WG; Tuchman M
Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
[TBL] [Abstract][Full Text] [Related]
16. Screening for neuroblastoma in children.
Morris JK
J Med Screen; 2002; 9(2):56. PubMed ID: 12133921
[No Abstract] [Full Text] [Related]
17. Biological analysis of neuroblastoma in mass screened negative cases.
Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
Prog Clin Biol Res; 1991; 366():603-8. PubMed ID: 2068179
[No Abstract] [Full Text] [Related]
18. Treatment complications in children diagnosed with neuroblastoma during a screening program.
Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastomas that might benefit from mass screening at 6 months of age in Japan.
Kaneko Y
Pediatr Blood Cancer; 2007 Feb; 48(2):245-6; author reply 247. PubMed ID: 16652345
[No Abstract] [Full Text] [Related]
20. Neuroblastoma screening in early life.
Suita S
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12226161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
